Primary and metastatic melanoma of the GI tract: clinical presentation, endoscopic findings, and patient outcomes
- PMID: 31659505
- DOI: 10.1007/s00464-019-07225-8
Primary and metastatic melanoma of the GI tract: clinical presentation, endoscopic findings, and patient outcomes
Abstract
Background and aims: Melanoma incidence has increased worldwide with a concurrent rise in both primary and metastatic melanomas of the gastrointestinal tract.
Materials and methods: This retrospective single-center case series includes patients with histopathology-confirmed primary or metastatic melanoma of the GI tract between 1998 and 2018.
Results: Thirty-four patients were identified for inclusion, of whom 7 were primary and 27 were metastatic cases of gastrointestinal melanoma. For both primary and metastatic cases, the majority of patients presented with frank or occult GI bleeding (57.1% and 70.4%). Primary and metastatic lesions were predominantly diagnosed endoscopically (100% and 63.0%), with 71.4% of primary lesions found at the anorectal junction and 51.9% of metastatic lesions in the small bowel. Endoscopically diagnosed lesions were either polypoid (50%) or a luminal mass (37.5%) in the majority of cases. Common features included: amelanotic (83%), ulcerated (50%), and friable (33.3%). All primary patients were treated with surgical excision or resection. Of the metastatic patients, 56% were resected. The median interval between initial primary and gastrointestinal metastases was 65 months (ranging from 1 month to 24 years). At the time of data analysis, 85.7% of primary and 29.6% of metastatic patients remained alive.
Conclusions: The majority of patients in this series were diagnosed endoscopically while investigating a source of gastrointestinal blood loss. Heightened clinical suspicion and recognition of the endoscopic features of gastrointestinal melanoma during evaluation of GI symptoms in a patient with a personal history of primary melanoma are advised.
Keywords: Anemia; Anorectal; Endoscopy; GI Bleeding; Melanoma.
References
-
- Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386. https://doi.org/10.1002/ijc.29210 - DOI - PubMed
-
- McLaughlin CC, Wu XC, Jemal A et al (2005) Incidence of noncutaneous melanomas in the U.S. Cancer 103:1000–1007. https://doi.org/10.1002/cncr.20866 - DOI - PubMed
-
- Meyers ML, Balch CM (1998) Diagnosis and treatment of metastatic melanoma. In: Balch CM, Houghton AN, Sober AJ, Song SJ (eds) Cutaneous melanoma, 3rd edn. Mo Quality Medical Publishing Inc, St Louis, pp 325–372
-
- Rose DM, Essner R, Hughes TMD et al (2001) Surgical resection for metastatic melanoma to the liver: the john wayne cancer institute and sydney melanoma unit experience. Arch Surg 136(8):950–955. https://doi.org/10.1001/archsurg.136.8.950 - DOI - PubMed
-
- Blecker D, Abraham S, Furth EE et al (1999) Melanoma in the gastrointestinal tract. Am J Gastroenterol 94:3427–3433. https://doi.org/10.1111/j.1572-0241.1999.01604.x - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
